Efficacy and safety of cholesterol-lowering treatment - Reply

Efficacy and safety of cholesterol-lowering treatment - Reply

Show other versions (1)

Bibliographic Details
Main Authors:	Baigent, C, Keech, A, Kearney, P, Collins, R, Simes, J, Collaboration, CTT
Format:	Journal article
Published:	2006

Similar Items

Efficacy and safety of cholesterol-lowering treatment - Reply
by: Baigent, C, et al.
Published: (2006)

Statins and diabetes - Reply
by: Kearney, P, et al.
Published: (2008)

Efficacy and safety of more intensive lowering of LDL cholesterol Reply
by: Baigent, C, et al.
Published: (2011)

Efficacy and safety of more intensive lowering of LDL cholesterol Reply
by: Baigent, C, et al.
Published: (2011)

Statins and diabetes - Authors' reply
by: Kearney, P, et al.
Published: (2008)

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.
by: Baigent, C, et al.
Published: (2005)

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.
by: Kearney, P, et al.
Published: (2008)

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised controlled trials of statins (vol 366, pg 1267, 2005)
by: Baigent, C, et al.
Published: (2008)

Benefits of lowering cholesterol in chronic kidney disease Reply
by: Baigent, C, et al.
Published: (2011)

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.
by: Baigent, C, et al.
Published: (2010)

Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy.
by: Cholesterol Treatment Trialists' (CTT) Collaboration, et al.
Published: (2012-01-01)

Benefits of reducing LDL cholesterol among 18,686 patients with diabetes: Meta-analysis of 14 radomized trials of a statin versus control
by: Kearney, P, et al.
Published: (2006)

Safety and efficacy of statins - Authors' reply
by: Collins, R, et al.
Published: (2017)

Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy.
by: Emberson, J, et al.
Published: (2012)

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.
by: Mihaylova, B, et al.
Published: (2012)

Statins for people at low risk of cardiovascular disease reply
by: Mihaylova, B, et al.
Published: (2012)

Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration. Oxford Cholesterol Study Group.
by: Wardle, J, et al.
Published: (1996)

Three-year follow-up of the Oxford Cholesterol Study: assessment of the efficacy and safety of simvastatin in preparation for a large mortality study.
by: Keech, A, et al.
Published: (1994)

Cholesterol, statins, and mortality - Reply
by: Lewington, S, et al.
Published: (2008)

Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration
by: Wardle, J, et al.
Published: (1996)

Cholesterol, statins, and mortality - Authors' reply
by: Lewington, S, et al.
Published: (2008)

Cholesterol and total mortality: need for larger trials.
by: Collins, R, et al.
Published: (1992)

Blood pressure lowering and cardiovascular risk - Authors' reply.
by: Sundström, J, et al.
Published: (2014)

LOW CHOLESTEROL AND CORONARY HEART-DISEASE - REPLY
by: Chen, Z, et al.
Published: (1991)

Lessons from the controversy over statins - Authors' reply.
by: Armitage, J, et al.
Published: (2016)

TRIALS OF ANTIPLATELET THERAPY - REPLY
by: Baigent, C, et al.
Published: (1994)

Cholesterol induced heart valve inflammation and injury: efficacy of cholesterol lowering treatment
by: Layan A El-Khatib, et al.
Published: (2020-12-01)

ANTIPLATELET PROPHYLAXIS - COMBINATION TREATMENT MAY CAUSE BLEEDING - THE SAME FOR MEN AND WOMEN - REPLY
by: Collins, R, et al.
Published: (1994)

Cost-effectiveness of lowering LDL cholesterol with statins and ezetimibe in chronic kidney disease
by: Mihaylova, B, et al.
Published: (2019)

Clinical effects of anticoagulants in suspected acute myocardial infarction - Reply
by: Collins, R, et al.
Published: (1997)

Cardiovascular disease: PCSK9 inhibition: a new player in cholesterol-lowering therapies?
by: Preiss, D, et al.
Published: (2017)

Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: is it cost-effective?
by: Glasziou, P, et al.
Published: (2002)

Cholesterol and risk of stroke - Reply
by: Qizilbash, N, et al.
Published: (1996)

CHOLESTEROL LOWERING TRIALS IN THEIR EPIDEMIOLOGIC CONTEXT
by: Collins, R
Published: (1993)

Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.
by: Colquhoun, D, et al.
Published: (2004)

Cholesterol and lipids
by: Baigent, C, et al.
Published: (2008)

Aspirin in the primary prevention of vascular disease Reply
by: Baigent, C, et al.
Published: (2009)

Aspirin in the primary prevention of vascular disease Reply
by: Baigent, C, et al.
Published: (2009)

MRC BHFHeart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience
by: Meade, T, et al.
Published: (1999)

PROTOCOL FOR A PROSPECTIVE COLLABORATIVE OVERVIEW OF ALL CURRENT AND PLANNED RANDOMIZED TRIALS OF CHOLESTEROL TREATMENT REGIMENS
by: Downs, J, et al.
Published: (1995)